| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/29/2007 | WO2006096491A3 Anti-ctla-4 antibody compositions |
| 03/29/2007 | WO2006079076A3 Yersinia spp. polypeptides and methods of use |
| 03/29/2007 | WO2006076683A3 Isolation and detection of pathogenic prions |
| 03/29/2007 | WO2006072625A8 Anti-kir combination treatments and methods |
| 03/29/2007 | WO2006067632A3 Saccharide conjugate vaccines |
| 03/29/2007 | WO2006060787A3 Delaying or preventing onset of multiple sclerosis |
| 03/29/2007 | WO2006014965A3 Pharmaceutical formulation and process |
| 03/29/2007 | WO2006013336A9 Hpv vaccine comprising peptides from host cell proteins |
| 03/29/2007 | WO2006009682A3 Glue compositions for lung volume reduction |
| 03/29/2007 | WO2005120558A3 Methods for making compositions comprising heat shock proteins or alpha-2-macroglobulin for the treatment of cancer and infectious disease |
| 03/29/2007 | WO2005097211A3 Compositions as adjuvants to improve immune responses to vaccines and methods of use |
| 03/29/2007 | WO2005053505A8 Use of gene ncsag4 for the diagnosis and prevention of neosporosis and as a marker for analysis of the pathogenesis |
| 03/29/2007 | WO2005035730A3 Dna sequences of the botulinum neurotoxin complex of type a-hall (allergan) strain |
| 03/29/2007 | WO2004043399A3 Methods and compositions for inducing immune responses and protective immunity by priming with alphavirus replicon vaccines |
| 03/29/2007 | US20070074300 Sialidase inhibitors for the treatment of cardiovascular disease |
| 03/29/2007 | US20070074296 RTD receptor |
| 03/29/2007 | US20070073048 Hiv polynucleotides and polypeptides derived from botswana mj4 |
| 03/29/2007 | US20070073047 Genes overexpressed by ovarian cancer and their use in developing novel therapeutics |
| 03/29/2007 | US20070073044 Homogeneous preparations of il-28 and il-29 |
| 03/29/2007 | US20070073042 Novel MHC II associated peptides |
| 03/29/2007 | US20070072916 Amino ceramide-like compounds and therapeutic methods of use |
| 03/29/2007 | US20070072822 STAT3 agonists and antagonists and therapeutic uses thereof |
| 03/29/2007 | US20070072266 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof. therapeutic uses thereof |
| 03/29/2007 | US20070072260 Mixture comprising serum complement system protein (INSP163) use in preparation of vaccines and antibodies for treatment and prevention of infection, cell proliferative, skin, neurodegenerative, bone, inflammatory, respiratory system and autoimmune disorders |
| 03/29/2007 | US20070072240 Method for producing an in vitro expression library |
| 03/29/2007 | US20070072198 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 03/29/2007 | US20070072177 Rabies virus G protein specific immunoglobulin for use in prevention and treatment of viral infections |
| 03/29/2007 | US20070072176 Novel peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis C virus |
| 03/29/2007 | US20070071827 Polypeptides and Polynucleotides for Enhancing Immune Reactivity to HER-2 Protein |
| 03/29/2007 | US20070071795 Antibodies as Growth Promoting Agents |
| 03/29/2007 | US20070071776 Recombinant Vaccine Against Fish Infectious Diseases |
| 03/29/2007 | US20070071775 Attenuated strains of vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination |
| 03/29/2007 | US20070071774 Protein D - an IgD-binding protein of Haemophilus influenzae |
| 03/29/2007 | US20070071773 Compositions and methods for the treatment and prophylaxis of infections caused by gram positive bacteria |
| 03/29/2007 | US20070071772 reducing or inhibiting invasiveness and metastasis of tumor cells that produce globotriaosylceramide (Gb3) |
| 03/29/2007 | US20070071771 Method for limiting the growth of cancer cells using an attenuated measles virus |
| 03/29/2007 | US20070071770 Recombinant MVA virus, and the use thereof |
| 03/29/2007 | US20070071769 Recombinant MVA virus, and the use thereof |
| 03/29/2007 | US20070071768 RNAIII-inhibiting peptide (RIP) with antimicrobial peptide such as cathelicidin, capable of binding and neutralizing lipidic and polyanionic components of bacterial cell envelope; infections from Staphylococcus and Bacillus; antibiotic resistance; cellulitis, keratitis, osteomyelitis, septic arthrititis |
| 03/29/2007 | US20070071767 Polypeptides used for induction of cytotoxic T lymphocytes or activation of human leukocyte antigens (HLA), administered as anticarcinogenic vaccines; immunology |
| 03/29/2007 | US20070071766 Compositions comprising fungal immunomodulatory protein and use thereof |
| 03/29/2007 | US20070071765 Compositions for Immunotherapy and Uses Thereof |
| 03/29/2007 | US20070071764 conjugated polymer drug contains toxin protein and polyethylene glycol; treating autoimmune diseases, such as multiple sclerosis, type 1 diabetes, psoriasis, inflammatory bowel disease, dermatitis, rheumatoid arthritis, psoriasis; asthma, allergy, restinosis, fibrosis, scleroderma, glomerulonephritis |
| 03/29/2007 | US20070071763 Clostridium difficile focussed antibodies |
| 03/29/2007 | US20070071762 Comprehensive diagnostic testing procedures for personalized anticancer chemotherapy (pac) |
| 03/29/2007 | US20070071761 treatment of colon tumor with a mixture of chemotherapeutic agent selected from cyclophosphamide or doxorubicin and an antigen binding fragment; synergistic potentiation; rheumatoid arthritis |
| 03/29/2007 | US20070071760 TACI (transmembrane activator or Calcium-Modulating Cyclophylin Ligand-interactor); used to suppress proliferation-inducing functions of BlyS (B-lymphocyte stimulator) and APRIL (a proliferation-inducing ligand); including non-Hodgkin's lymphoma |
| 03/29/2007 | US20070071759 Antibody-immune cell ligand fusion protein for cancer therapy |
| 03/29/2007 | US20070071758 CEACAM1 Based Cancer Therapy and Diagnosis |
| 03/29/2007 | US20070071757 detecting and diagnosing cancer or the likelihood of developing cancer based on the presence or absence of expression of PRDM11 or TBX21 or proteins encoded by those genes |
| 03/29/2007 | US20070071756 Delivery of an agent to ameliorate inflammation |
| 03/29/2007 | US20070071755 Novel nucleolar GTPases and method for controlling proliferation of cells |
| 03/29/2007 | US20070071754 Method to ameliorate inflammation |
| 03/29/2007 | US20070071753 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 85 (gpr85) |
| 03/29/2007 | US20070071752 Sphingosine kinase enzyme |
| 03/29/2007 | US20070071751 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 03/29/2007 | US20070071750 Comprises heavy and light chain; treating envenomation by administering to neutralize in vivo effect |
| 03/29/2007 | US20070071749 Using cocktail comprising endothelial growth factor specific immunoglobulin and gemcitabine to treat and/or prevent pancreatic cancer |
| 03/29/2007 | US20070071748 Treatment with anti-vegf antibodies |
| 03/29/2007 | US20070071747 Use of TNFalpha inhibitor for treatment of erosive polyarthritis |
| 03/29/2007 | US20070071746 C/CLP antagonists and methods of use thereof |
| 03/29/2007 | US20070071745 Modified antigen binding molecules with altered cell signaling activity |
| 03/29/2007 | US20070071744 Agents which bind to epitopes of glycoprotein VI |
| 03/29/2007 | US20070071743 Novel human cell surface protein with immunoglobulin folds, BGS-19 |
| 03/29/2007 | US20070071742 bind ICAM-1 and inhibit pathogen infection of cells expressing ICAM-1; for protection against human rhinovirus (HRV), coxackie A virus, respiratory syncytial virus (RSV), or malaria |
| 03/29/2007 | US20070071741 OCL-2A3 compositions and uses thereof |
| 03/29/2007 | US20070071730 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 03/29/2007 | US20070071726 replication-defective recombinant adenovirus comprising a heterologous nucleic acid sequence encoding an antigenic determinant of Plasmodium falciparum; ntigenic determinant comprises an immunogenic peptide of the circumsporozoite protein; viral vectors |
| 03/29/2007 | US20070071722 Nucleotide vaccine composition |
| 03/29/2007 | US20070071719 Compositions and methods for regulation of tumor necrosis factor-alpha |
| 03/29/2007 | US20070071718 Using endothelial growth factor specific monoclonal antibody for treatment and prevention of leukemia; immunotherapy |
| 03/29/2007 | US20070071717 Treatment of B cells with IL-21 and B cell activators induces Granzyme B production |
| 03/29/2007 | US20070071714 Stem cell factor |
| 03/29/2007 | US20070071683 Ultrasonic concentration of carrier particles |
| 03/29/2007 | US20070071682 Methods for testing vaccine candidates against bacterial infection in rodents |
| 03/29/2007 | US20070071677 Non-toxic membrane-translocating peptides |
| 03/29/2007 | US20070071674 Polynucleotides encoding novel isoforms of IGSF9 |
| 03/29/2007 | US20070068960 Pill dispenser |
| 03/29/2007 | DE102005046258A1 Immunosorbent for treating insulin resistance or metabolic syndrome comprises a polymeric support to which are attached ligands that specifically bind to interleukin-6 |
| 03/29/2007 | CA2623445A1 Comprehensive diagnostic testing procedures for personalized anticancer chemotherapy (pac) |
| 03/29/2007 | CA2623415A1 Tdf-related compounds and analogs thereof |
| 03/29/2007 | CA2623391A1 Immunogenic fragments of t-cell receptor constant domains and peptides derived therefrom |
| 03/29/2007 | CA2623208A1 Fragrance dispensing device |
| 03/29/2007 | CA2623176A1 Protein a production and purification without using animal derived components |
| 03/29/2007 | CA2623016A1 Treatment of b cell diseases using anti-germline antibody binding agents |
| 03/29/2007 | CA2622997A1 A liposome composition to cause lysis of cells and pathogens |
| 03/29/2007 | CA2622869A1 Modifying leukocyte function |
| 03/29/2007 | CA2622739A1 Ancestral dengue virus envelope protein sequence |
| 03/29/2007 | CA2622461A1 Chemo-immunotherapy method |
| 03/28/2007 | EP1767642A1 Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof |
| 03/28/2007 | EP1767641A1 Antigenic neisserial peptides |
| 03/28/2007 | EP1767639A1 Oral vaccine against protozoiasis using genetically modified plant |
| 03/28/2007 | EP1767638A2 Mutation associated with epilepsy |
| 03/28/2007 | EP1767637A1 Mutation associated with epilepsy |
| 03/28/2007 | EP1767636A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 03/28/2007 | EP1767633A1 Novel polypeptide useful for diagnosis and treatment of cancer |
| 03/28/2007 | EP1767627A1 Anti-perp antibody |
| 03/28/2007 | EP1767626A1 Peroral vaccine carrier system |
| 03/28/2007 | EP1767543A1 Novel bee venom polypeptides and methods of use thereof |
| 03/28/2007 | EP1767542A2 HLA-A2. 1 binding peptides and their uses |